v3.26.3
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Equity Award Programs
Common stock
Common stock
Equity Award Programs
Common stock and additional paid-in capital
Common stock and additional paid-in capital
Equity Award Programs
Accumulated deficit
Accumulated other comprehensive loss
Beginning balance (in shares) at Dec. 31, 2024     92.2          
Beginning balance at Dec. 31, 2024 $ 485       $ 1,617   $ (1,132) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)     13.6 0.1        
Issuance of common stock 142       142      
Stock-based compensation 16       16      
Net loss (112)           (112)  
Ending balance (in shares) at Mar. 31, 2025     105.9          
Ending balance at Mar. 31, 2025 531       1,775   (1,244) 0
Beginning balance (in shares) at Dec. 31, 2024     92.2          
Beginning balance at Dec. 31, 2024 485       1,617   (1,132) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (247)              
Ending balance (in shares) at Sep. 30, 2025     107.1          
Ending balance at Sep. 30, 2025 436       1,815   (1,379) 0
Beginning balance (in shares) at Mar. 31, 2025     105.9          
Beginning balance at Mar. 31, 2025 531       1,775   (1,244) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)       0.5        
Issuance of common stock   $ 3       $ 3    
Stock-based compensation 15       15      
Ending balance (in shares) at Jun. 30, 2025     106.4          
Ending balance at Jun. 30, 2025 549       1,793   (1,244) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)       0.7        
Issuance of common stock   8       8    
Stock-based compensation 14       14      
Net loss (135)           (135)  
Ending balance (in shares) at Sep. 30, 2025     107.1          
Ending balance at Sep. 30, 2025 $ 436       1,815   (1,379) 0
Beginning balance (in shares) at Dec. 31, 2025 125.3   125.3          
Beginning balance at Dec. 31, 2025 $ 631       2,116   (1,485) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)       0.2        
Issuance of common stock   3       3    
Stock-based compensation 19       19      
Other comprehensive loss (1)             (1)
Net loss (128)           (128)  
Ending balance (in shares) at Mar. 31, 2026     125.5          
Ending balance at Mar. 31, 2026 $ 524       2,138   (1,613) (1)
Beginning balance (in shares) at Dec. 31, 2025 125.3   125.3          
Beginning balance at Dec. 31, 2025 $ 631       2,116   (1,485) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss $ (347)              
Ending balance (in shares) at Sep. 30, 2026 127.6   127.6          
Ending balance at Sep. 30, 2026 $ 358       2,192   (1,832) (2)
Beginning balance (in shares) at Mar. 31, 2026     125.5          
Beginning balance at Mar. 31, 2026 524       2,138   (1,613) (1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)       1.5        
Issuance of common stock   16       16    
Stock-based compensation 15       15      
Net loss (91)           (91)  
Ending balance (in shares) at Jun. 30, 2026     127.0          
Ending balance at Jun. 30, 2026 464       2,169   (1,704) (1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)       0.6        
Issuance of common stock   $ 7       $ 7    
Stock-based compensation 16       16      
Other comprehensive loss (1)             (1)
Net loss $ (128)           (128)  
Ending balance (in shares) at Sep. 30, 2026 127.6   127.6          
Ending balance at Sep. 30, 2026 $ 358       $ 2,192   $ (1,832) $ (2)